Michael Wenger to Rituximab
This is a "connection" page, showing publications Michael Wenger has written about Rituximab.
Connection Strength
0.028
-
Obinutuzumab plus chlorambucil in patients with CLL and coexisting conditions. N Engl J Med. 2014 Mar 20; 370(12):1101-10.
Score: 0.028
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.